Abstract:Type 2 diabetes (T2D) is a common metabolic disorder characterized by dysregulation of glucose metabolism. Genome-wide association studies have defined hundreds of signals associated with T2D and related metabolic traits, predominantly in noncoding regions. While pancreatic islets have been a focal point given their central role in insulin production and glucose homeostasis, other metabolic tissues, including liver, adipose, and skeletal muscle, also contribute to T2D pathogenesis and risk. Here, we examined context-specific genetic regulation under basal and stimulated states. Using LHCN-M2 human skeletal muscle cells, we generated transcriptomic profiles and characterized regulatory activity of 327 metabolic trait-associated variants via a massively parallel reporter assay (MPRA). To identify condition-specific effects, we compared four different conditions: (1) undifferentiated, or (2) differentiated with basal media, (3) media supplemented with the AMP analog AICAR (to simulate exercise) or (4) media containing sodium palmitate (to induce insulin resistance). RNA-seq revealed these treatments extensively perturbed transcriptional regulation, with 498-3,686 genes showing significant differential expression between pairs of conditions. Among differentially expressed genes, we observed enrichment of relevant biological pathways including muscle differentiation (undifferentiated vs. differentiated), oxidoreductase activity (differentiated vs. AICAR), and glycogen binding (differentiated vs. palmitate). The results of our MPRA found broadly different levels of activity between all conditions. Our MPRA screen revealed a shared set of 7 variants with significant allelic activity across all conditions, along with a proportional number of variants showing condition-specific allelic bias and the total number of active oligos per condition. We found that a lead variant for serum triglyceride levels, rs490972, overlaps SP transcription factor motifs and has differential regulatory activity between conditions. Comparison of MPRA activity with paired gene expression data allowed us to predict that regulatory activity at this locus is mediated by SP1 transcription factor binding. While several of the MPRA variants have been previously characterized in other metabolic tissues, none have been studied in these stimulated states. Together, this work uncovers context-dependent transcriptomic and regulatory dynamics of T2D- and metabolic trait-associated variants in skeletal muscle cells, offering new insights into their functional roles in metabolic processes.

A Novel Type 2 Diabetes Risk Allele Increases the Promoter Activity of the Muscle-Specific Small Ankyrin 1 Gene

Skeletal Muscle Overexpression of Sank1.5 in Transgenic Mice Does Not Predispose to Type 2 Diabetes

Association of PI3K/AKT/mTOR Pathway Genetic Variants with Type 2 Diabetes Mellitus in Chinese.

CDKN2A/B T2D Genome-Wide Association Study Risk SNPs Impact Locus Gene Expression and Proliferation in Human Islets

The Genetic Regulatory Signature of Type 2 Diabetes in Human Skeletal Muscle

Ankyrin-B Metabolic Syndrome Combines Age-Dependent Adiposity With Pancreatic Beta Cell Insufficiency

Functional dissection of metabolic trait-associated gene regulation in steady state and stimulated human skeletal muscle cells

Genome-wide Meta-Analysis Associates GPSM1 with Type 2 Diabetes, a Plausible Gene Involved in Skeletal Muscle Function

Genetic Variants of SIRT1 Gene Promoter in Type 2 Diabetes

A regulatory variant rs9379874 in T1D risk region 6p22.2 affects BTN3A1 expression regulating T cell function

Haplotypes of the Mutated SIRT2 Promoter Contributing to Transcription Factor Binding and Type 2 Diabetes Susceptibility

Identification of New Genetic Risk Variants for Type 2 Diabetes

Effects of Genetic Variants of Nuclear Receptor Y on the Risk of Type 2 Diabetes Mellitus.

A Novel Polymorphism (rs35612982) in CDKAL1 is a Risk Factor of Type 2 Diabetes: A Case-Control Study

Enhancer-Gene Interaction Analyses Identified the Epidermal Growth Factor Receptor As a Susceptibility Gene for Type 2 Diabetes Mellitus.

Relationship between type 2 diabetes mellitus and a novel polymorphism C698T in C5L2 in the Chinese Han population

Contribution of the Akt2 Gene to Type 2 Diabetes in the Chinese Han Population.

Activating Transcription Factor 6 (atf6) Sequence Polymorphisms in Type 2 Diabetes and Pre-Diabetic Traits

A Novel Polymorphism in Protein Kinase Amp-Activated Catalytic Subunit Alpha 2 (prkaa2) is Associated with Type 2 Diabetes in the Han Chinese Population

Genome-Wide Identification of N6-Methyladenosine Associated SNPs As Potential Functional Variants for Type 1 Diabetes

Type 2 Diabetes Modifies the Association of CAD Genomic Risk Variants With Subclinical Atherosclerosis